HEALTH ACTION INTERNATIONAL (HAI) MAINTAINS A VIBRANT GLOBAL NETWORK OF INDEPENDENT EXPERTS IN 70 COUNTRIES AROUND THE WORLD, SOME OF WHOM ARE LISTED BELOW. TOGETHER WE SHARE INFORMATION AND EXPERTISE TO SOLVE PROBLEMS RELATED TO MEDICINES ACCESS INTERNATIONALLY.

Dr Adriana Ivama Brummell

Dr Adriana Ivama Brummell,PhD, is an international health, health surveillance and regulation specialist. She has international experience in engaging stakeholders for promoting policy and regulatory changes regarding medicines and other health technologies, as well as strengthening the education and practice of health professionals with an interprogrammatic approach. Focus areas of work include health system reforms; policies, regulation, research, access, incorporation and rational use of medicines and other health technologies; pharmaceutical services based in primary health care; human rights and social participation.

Line Buan

Line Buan is a Norwegian hospital pharmacist with a passion for rational medicine use and availability for all, and against antibiotic resistance and illegal medicines.

Dr Constantinos Christopoulos

Dr Constantinos Christopoulos, MD, PhD, is a Consultant Physician and Haematologist, and Director of the Department of Internal Medicine at the Amalia Fleming Hospital in Athens, Greece. His interests include medical education, cost-effectiveness analysis, and the promotion of the rational use of drugs. He is a member of HAI Europe association and has translated WHO/HAI’s manual “Understanding and Responding to Pharmaceutical Promotion – A Practical Guide” into Greek.

Andrew Defor

Andrew is a Professor of Global Health Security and Diplomacy, Senior Diplomatic & Government Relations Strategist and a Clinical Pharmacologist by training. His work focuses on global health security, foreign policy, diplomacy, multilateral negotiations, policy advocacy and government relations. He is currently Chief Executive Director and Director of Policy and Government Relations at the Center for Global Health Security and Diplomacy, where he directs global health foreign policy research and serves as Chief Advisor to diplomats and officials from G7/G20 governments, WHO, World Bank, AU, EU and NATO. Prior to being appointed as Chief Executive Director, Andrew worked as a Policy Advisor in various departments at the World Health Organization including the departments of essential drugs and medicines and Health Financing. He has also consulted for a number of NGOs including CARE Canada and UN Agencies like UNICEF and UNESCO. Andrew was honored as Senior Fellow at the Canadian International Council and has published widely at the UN and in high-ranking peer-reviewed journals. He has taught Global Affairs at Seneca College, Niagara and Centennial Colleges and  is currently a Professor at Mohawk College and Algonquin University Colleges in Canada. Andrew holds qualifications from the University of London and the University of Oxford, and has degrees in Pharmacology, Biotechnology, International Affairs and Global Health.

Dr Nafis Faizi

Dr Nafis Faizi is an Assistant Professor in Community Medicine at JN Medical College, AMU, Aligarh. His primary research areas include adolescent health, non-communicable diseases, randomised impact evaluations and health systems, primary health care and diseases at the intersection of public health and poverty. Apart from primary research, he works as a trainer for the Epidemiological Research Unit and Public Health Research and Assistance Society (PHRASe)  for different aspects of research methods, design, biostatistics, software and research dissemination. He advocates health as a fundamental right and for its public provision.

Vildan Gocmen

Vildan Gocmen is a pharmacist working at the Turkish T.C. Ministry of Health Yalova Provincial Health Directorate. He also organises regional activities and projects regarding the rational use of medicines for pharmacists, physicians and the general public.

Joel Lexchin

Joel Lexchin, MD, Professor Emeritus, has been active in the HAI network for 30 years, and is now a member of the HAI Europe Association. He has researched, written, and talked publicly about pharmaceutical policy, both in Canada and internationally. Prof. em. Lexchin is currently based at York University, in Toronto.

Donald W. Light

Professor Donald W. Light is an activist scholar who has published works on ethical challenges posed by commercial health insurance, the effects of managed care on professional care, and the consequences of developing new medicines through patent-driven research. Key documents include: The Risks of Prescription Drugs (Columbia University Press, 2010) and Good Pharma: The Public Health Model of the Mario Negri Institute (Palgrave 2015). Prof Light is affiliated with Rowan University School of Osteopathic Medicine.

Dr Rusla Anne Springer

Dr Rusla Anne Springer is an Assistant Professor in the College of Nursing at the University of Saskatchewan. Herwork focuses on the ethics of pharmaceutical industry omnipresence in healthcare research and practice. Her area of inquiry is among the most pressing of the social, political, economic, scientific and ethical challenges facing the sustainability of health care systems around the world. Dr Springer’s published works in this area problematise the relationship between the pharmaceutical industry and the profession of nursing and are intended to raise awareness amongst nurses about the magnitude of the purview of the pharmaceutical industry and its insidious ‘creep’ into nursing’s intimate relational spaces.

Staffan Svensson

Dr Staffan Svensson, MD, PhD, is a specialist in Family Medicine and Clinical Pharmacology who works at the GP Centre in Hjällbo, a suburb of Gothenburg, Sweden. He has a long-standing interest in rational drug use, side-effects, medicalisation and overdiagnosis. He is active in a committee of the Swedish Association of General Practice that deals with these issues, and has been a member of the HAI Europe Association since the early 1990’s.